✦ LIBER ✦

Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study

✍ Scribed by Reshef, A.; Moldovan, D.; Obtulowicz, K.; Leibovich, I.; Mihaly, E.; Visscher, S.; Relan, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Recombinant Human C1 Inhibit

✍ Suez, D.; Moldovan, D.; Baker, J.W.; Kivity, S.; Relan, A.; Reshef, A.; Levy, R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Recombinant human C1-inhibitor for the t

✍ Zuraw, Bruce; Cicardi, Marco; Levy, Robyn J.; Nuijens, Jan H.; Relan, Anurag; Vi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Frequency of Dosing for Hereditary Angio

✍ Banta, E.; Mende, C.; Rhoads, C.; Craig, T. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Sustained Response Following Acute Treat

✍ Li, H. Henry; Riedl, Marc A.; Bernstein, Jonathan A.; Lumry, William R.; Reshef, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Recombinant human C1-inhibitor in the tr

✍ Goda Choi; Maarten R. Soeters; Henriette Farkas; Lilian Varga; Krystyna Obtulowi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Clinical Studies of Recombinant Human C1

✍ Nuijens, J.; Verdonk, R.; Giannetti, B.; Visscher, S.; van Doorn, M.; Resink, T. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB